Under construction – not a live service
Sign in
Taking people in United StatesNo phase

Registry tracking how amyotrophic lateral sclerosis affects people in the United States

Collects information on people with ALS to learn who gets the disease.

Plain-language title generated from the registry record
Registry title: The National Amyotrophic Lateral Sclerosis Registry

Key facts

Where
Atlanta, United StatesSee the site

Where in United States

  • CDCAtlanta, United StatesTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Centers for Disease Control and Prevention
Trial code
NCT01772602
Record updated
29 April 2026
Original description
The purpose of this registry is to (A) better describe the incidence and prevalence of Amyotrophic Lateral Sclerosis (ALS) in the United States;(B) examine appropriate factors, such as environmental and occupational, that may be associated with the disease; (C) better outline key demographic factors (such as age, race or ethnicity, gender, and family history of individuals who are diagnosed with the disease) associated with the disease; and (D) better examine the connection between ALS and other motor neuron disorders that can be confused with ALS, misdiagnosed as ALS, and in some cases progress to ALS.Read full original descriptionShow less

The National Amyotrophic Lateral Sclerosis Registry

The purpose of this registry is to (A) better describe the incidence and prevalence of Amyotrophic Lateral Sclerosis (ALS) in the United States;(B) examine appropriate factors, such as environmental and occupational, that may be associated with the disease; (C) better outline key demographic factors (such as age, race or ethnicity, gender, and family history of individuals who are diagnosed with the disease) associated with the disease; and (D) better examine the connection between ALS and other motor neuron disorders that can be confused with ALS, misdiagnosed as ALS, and in some cases progress to ALS.

Inclusion: U.S. citizens 18 years of age or older.

Exclusion: -.

ClinicalTrials.gov NCT01772602